Assignee profile:

Diatex, Inc.

City:

San Antonio, Texas

Country:

United States

Published Applications:

16

Last publication date:

2021-11-18

Patent Grants:

12

Last grant date:

2018-11-27

Top Inventors for applications by Diatex, Inc.

These are the the leading inventors for applications assigned to Diatex, Inc.:

Recent patent applications by Diatex, Inc.

Diatex, Inc. based in San Antonio, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-11-18
US20210355066A1
Chemistry; metallurgy

CB-0406 choline salt

#2 | 2021-11-18
US20210355065A1
Chemistry; metallurgy

CB-0406 tromethamine salt

#3 | 2018-08-02 ✅ Patent 10,137,112 granted on 2018-11-27
US20180214420A1
Human necessities

Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent

#4 | 2016-09-29 ✅ Patent 9,845,285 granted on 2017-12-19
US20160280636A1
Chemistry; metallurgy

Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto

#5 | 2016-09-22 ✅ Patent 9,801,860 granted on 2017-10-31
US20160271111A1
Human necessities

Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent

#6 | 2016-02-25 ✅ Patent 9,433,612 granted on 2016-09-06
US20160051520A1
Human necessities

Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent

#7 | 2015-09-17 ✅ Patent 9,439,891 granted on 2016-09-13
US20150258053A1
Human necessities

Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent

#8 | 2015-08-13 ✅ Patent 9,233,914 granted on 2016-01-12
US20150225333A1
Chemistry; metallurgy

Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto

#9 | 2014-01-23 ✅ Patent 8,993,797 granted on 2015-03-31
US20140024852A1
Chemistry; metallurgy

Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto

#10 | 2012-09-13 ✅ Patent 8,507,719 granted on 2013-08-13
US20120232303A1
Chemistry; metallurgy

Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto

#11 | 2010-04-15 ✅ Patent 8,329,749 granted on 2012-12-11
US20100093855A1
Human necessities

Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia

#12 | 2010-04-15 ✅ Patent 8,354,448 granted on 2013-01-15
US20100093853A1
Human necessities

Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes

#13 | 2009-08-18 ✅ Patent 7,576,131 granted on 2009-08-18
US10382186
-

Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia

#14 | 2008-09-11 ✅ Patent 8,203,019 granted on 2012-06-19
US20080221018A1
Chemistry; metallurgy

Crystalline solid and amorphous forms of (−)- halofenate and methods related thereto

#15 | 2007-11-22
US20070270490A1
Human necessities

USE OF (-)(3-TRIHALOMETHYLPHENOXY)(4-HALOPHENYL) ACETIC ACID DERIVATIVES FOR TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES AND HYPERLIPIDEMIA

#16 | 2005-04-07
US20050075396A1
Human necessities

Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemia

Also check out Diatex, Inc.'s (San Antonio, United States) applicant profile with 4 patent applications submitted.

AssigneeID:

52771 ⎘